Document is current
Any future updates will be listed below
-
Authors
Miron, Gadi
Halimeh, Mustafa
Tietze, Simon
Holtkamp, Martin
Meisel, Christian
- License Information
-
More Information
Article History
Received: 10 October 2024
Accepted: 4 June 2025
First Online: 17 June 2025
Competing interests
: C.M. is part of patent applications to detect and predict clinical outcomes and to manage, diagnose, and treat neurological conditions, all of which are outside the submitted work, and declares no other financial or non-financial competing interests. M.H. reports personal fees from Angelini, Bial, Desitin, Eisai, Jazz Pharma, Neuraxpharm, Nutricia, and UCB within the last 3 years, outside the submitted work, and declares no non-financial competing interests. G.M., M.H., and S.T. declare no financial or non-financial competing interests.
